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Abstract. 
 
Proline-rich tyrosine kinase 2 (PYK2), a ty-
rosine kinase structurally related to focal adhesion ki-
nase (FAK), is implicated in regulating cytoskeletal
organization. However, mechanisms by which PYK2
participates in and regulates cytoskeletal organization
remain largely unknown. Here we report identiﬁcation
of PSGAP, a novel protein that interacts with PYK2
and FAK and contains multiple domains including a
pleckstrin homology domain, a rhoGTPase-activating
protein domain, and a Src homology 3 domain. PYK2
interacts with PSGAP Src homology 3 domain via the
carboxyl-terminal proline-rich sequence. PSGAP is
able to increase GTPase activity of CDC42 and RhoA
in vitro and in vivo. Remarkably, PYK2, but not FAK,
can activate CDC42 via inhibition of PSGAP-medi-
ated GTP hydrolysis of CDC42. Moreover, PSGAP is
localized at cell periphery in ﬁbroblasts in a pleckstrin
 
homology domain–dependent manner. Over expression
of PSGAP in ﬁbroblasts results in reorganization of
cytoskeletal structures and changes of cellular mor-
phology, which requires rhoGTPase-activating activity.
 
Taken together, our results suggest that PSGAP is a
signaling protein essential for PYK2 regulation of cy-
toskeletal organization via Rho family GTPases.
Key words: proline-rich tyrosine kinase 2 • focal ad-
hesion kinase • CDC42 • rhoGAP • PSGAP
 
Introduction
 
Integrin signaling triggered by the interaction of extracel-
lular matrix and cell-surface integrin is essential in regulat-
ing cell migration, cell growth, and cell survival (Hynes,
1992; Schwartz et al., 1995; Parsons, 1996). The potential
mediators of integrin signaling include protein kinases [fo-
cal adhesion kinase (FAK;
 
1
 
 Schaller et al., 1992), c-Src
(Kaplan et al., 1994), COOH-terminal Src kinase (Berg-
 
man et al., 1995), protein kinase C (Jaken et al., 1989; Barry
and Critchley, 1994), and phosphatidylinositol 3-kinase
(Chen and Guan, 1994; Guinebault et al., 1995)], adapter
proteins [Grb2 (Schlaepfer et al., 1994), Crk (Birge et al.,
1993), p130
 
Cas 
 
(Polte and Hanks, 1995; Harte et al., 1996),
and paxillin (Burridge et al., 1992)], and small GTP-pro-
tein guanine nucleotide exchange factors (C3G and Sos;
Tanaka et al., 1994). Although many components involved
in integrin signaling have been identified, the signaling
events that regulate cytoskeletal organization and cell mi-
gration remain to be elucidated. Two major classes of sig-
naling molecules (i.e., small GTP-binding protein Rho sub-
family members and protein tyrosine kinases) have been
found to participate in and regulate integrin signaling.
Small GTP-binding proteins of the Rho subfamily, partic-
ularly CDC42, Rac1, and RhoA, play important roles in di-
verse cellular events including actin cytoskeletal organiza-
tion, membrane trafficking, transcriptional regulation, and
cell growth control (Van Aelst and D’Souza-Schorey, 1997;
Hall, 1998). In fibroblasts, CDC42, Rac1, and RhoA func-
tion to organize actin cytoskeleton, including filopodium ex-
tension, lamellipodium formation, and generation of actin
stress fibers and focal adhesions, respectively (Ridley and
Hall, 1992; Nobes and Hall, 1995; Van Aelst and D’Souza-
Schorey, 1997; Hall, 1998). The ability of Rho family GTP-
ases to participate in signaling events is determined by the
ratio of GTP/GDP-bound forms in the cell. The cycling of
GTPases between active GTP-bound states and inactive
GDP-bound states is regulated by the opposing effects of
guanine nucleotide exchange factors, which enhance the ex-
change of bound GDP for GTP, and the GTPase-activating
 
Address correspondence to Wen-Cheng Xiong, Department of Pathology,
University of Alabama at Birmingham, Birmingham, AL 35294. Tel.:
(205) 975-7138. Fax: (205) 975-9927. E-mail: wxiong@path.uab.edu
 
1
 
Abbreviations used in this paper:
 
 AD, activation domain; 
 
b
 
-Gal,
 
b
 
-galactosidase; FAK, focal adhesion kinase; GAP, GTPase-activating
 
protein; GST, glutathione-S-transferase; PBD, p21-binding
 
 
 
domain of
PAK1; PH, pleckstrin homology; PYK2, proline-rich tyrosine kinase 2;
RBD, p21-binding
 
 
 
domain of rhotekin; SH3, Src homology 3. 
The Journal of Cell Biology, Volume 152, 2001 972
 
proteins (GAPs), which increase hydrolysis of bound GTP.
In addition, GTPases are regulated by guanine nucleotide
dissociation inhibitors, which can inhibit both the exchange
of GTP and the hydrolysis of bound GTP.
In addition to small GTP-binding protein Rho family
members, tyrosine kinases are essential in integrin signal-
ing. A major family of tyrosine kinases regulating integrin
signaling and localized at focal adhesions is the FAK fam-
ily (Guan and Shalloway, 1992; Schaller et al., 1992). FAK
family tyrosine kinases include FAK and proline-rich ty-
rosine kinase 2 (PYK2), also known as cellular adhesion
kinase 
 
b
 
, related adhesion focal tyrosine kinase, and cal-
cium-dependent tyrosine kinase (Avraham et al., 1995;
Lev et al., 1995; Sasaki et al., 1995; Li and Earp, 1997).
FAK and PYK2 are highly homologous to each other in
structure. Both contain a central catalytic domain and
large amino (NH
 
2
 
) and carboxyl (COOH)-terminal non-
catalytic regions (Avraham et al., 1995; Lev et al., 1995;
Sasaki et al., 1995; Li and Earp, 1997). The COOH-termi-
nal region has two proline-rich sequences and a focal
adhesion-targeting (FAT) domain. The proline-rich se-
quences provide the binding motifs for Src homology
3 (SH3) domains of p130
 
Cas
 
 (Crk-associated substrate),
Graf (GTPase regulator associated with FAK), and Paps
[pleckstrin homology (PH) and SH3 domain containing
ArfGAP proteins] (Polte and Hanks, 1995; Hildebrand et
al., 1996; Astier et al., 1997; Manie et al., 1997; Ohba et al.,
1998; Xiong et al., 1998; Andreev et al., 1999). The FAT
domain that is both necessary and sufficient for the target-
ing of FAK/PYK2 to focal adhesions is critical for the as-
sociation with the cytoskeletal proteins paxillin (Hilde-
brand et al., 1993; Tachibana et al., 1995; Salgia et al., 1996;
Li and Earp, 1997; Xiong et al., 1998). In addition to these
common binding partners, PYK2 also interacts with pro-
teins that do not bind to FAK. For example, PYK2, but
not FAK, interacts with Nirs (mammalian homologues of
 
Drosophila
 
 retinal degeneration B) (Lev et al., 1999).
While FAK plays an important role in regulating inte-
grin-mediated cell migration and cell spreading (Illc et al.,
1995; Carey et al., 1996; Richardson et al., 1997), few in-
sights were available regarding the role of PYK2 in regu-
lating integrin signaling. PYK2 is implicated in diverse cel-
lular events including regulation of neurotransmission or
neuroplasticity (Lev et al., 1995), osteoclastic bone resorp-
tion, protein secretion (Fuortes et al., 1999), and cell
growth control (Xiong and Parsons, 1997; Zhao et al.,
2000). We have found that FAK and PYK2 mediate differ-
ent effects on cytoskeletal organization. Overexpression of
PYK2, but not FAK, in fibroblasts induces reorganization
of cytoskeletal structures, and PYK2-induced cytoskeletal
reorganization can be rescued by FAK. In addition, ex-
pression of PYK2, but not FAK, in fibroblasts induces ap-
optosis (Xiong and Parsons, 1997). The mechanisms un-
derlying PYK2-induced cytoskeletal reorganization and
the differential functions between PYK2 and FAK are
largely unknown.
In an attempt to study the mechanisms involved in
PYK2-mediated cytoskeletal reorganization, we used
the yeast two-hybrid cloning system to identify proteins
that interact with PYK2. Here
 
 
 
we report the identifica-
tion of a novel PYK2-interacting protein, PSGAP (PH
and SH3 domain containing rhoGAP protein). PSGAP
stimulates GTPase activity of CDC42 and RhoA both in
vitro and in vivo. PYK2 bound to PSGAP SH3 domain,
 
inhibited the effect of PSGAP on CDC42, and activated
CDC42. Our results suggest that PSGAP is a mediator
for PYK2 to regulate cytoskeletal organization via small
G proteins.
 
Materials and Methods
 
Reagents
 
Rabbit antisera against PSGAP were raised using a glutathione-S-trans-
ferase (GST) fusion protein containing the COOH-terminal 60 amino
acids of PSGAP SH3 domain (amino acid residues 731–786). The anti–
PSGAP antibodies were purified by affinity column using PSGAP anti-
gen. Monoclonal antibodies were purchased from Santa Cruz Biotechnology,
Inc. (anti–Myc), Sigma-Aldrich (anti–Flag), or Transduction Laboratories
(anti–PYK2). Mouse brain mRNAs and primers for RACE-PCR were
purchased from CLONTECH Laboratories, Inc.
 
Yeast Two-Hybrid Studies
 
The PYK2 COOH terminus (amino acid residues 781–1009) was gener-
ated by PCR, subcloned into pGBT10 (pGBT10-PYK2
 
D
 
1-781; provided
by Dr. Ian Macara, University of Virginia, Charlottesville, VA), and used
as bait to screen a mouse brain cDNA library fused to the GAL4 tran-
scriptional activation
 
 
 
domain (provided by Dr. Jeff Chamberlain, Univer-
sity of Michigan, East Lansing, MI). The Y190 yeast strain
 
 
 
was first trans-
formed with pGBT10-PYK2
 
D
 
1-781 and subsequently with
 
 
 
the mouse
brain cDNA library. Positive transformants were selected by growth with-
out tryptophan (Trp
 
2
 
), leucine
 
 
 
(Leu
 
2
 
), and histidine (His
 
2
 
), and by
 
b
 
-galactosidase (
 
b
 
-Gal) activity (Huang et al., 2000). Plasmid DNA was
purified from
 
 
 
His
 
1
 
 
 
b
 
-Gal
 
1
 
 colonies, and retransformed into
 
 
 
yeast with dif-
ferent bait vectors to determine specificity.
To characterize binding between PYK2 and PSGAP, plasmids encod-
ing PYK2 and PSGAP mutants were cotransformed into yeast Y190. In-
teractions were characterized by growth of transformed yeasts on plates
without leucine, tryptophan, or histidine and by 
 
b
 
-Gal activity. Binding af-
finity of PSGAP with PYK2 COOH terminus, and PYK2 proline mutants
was also characterized by a liquid 
 
b
 
-Gal assay as described previously
(Huang et al., 2000).
 
Cloning of Full-Length cDNA of PSGAP
 
RACE-PCR was employed to obtain entire open reading frame using the
Marathon cDNA Amplification Kit and Advantage cDNA Polymerase
(CLONTECH Laboratories, Inc.) following the manufacturer’s instruc-
tions. Two specific primers designed from mouse PSGAP sequences and
two primers directed toward the cDNA adapters were used for RACE-
PCR. The first primer, 5
 
9
 
-GACCCAAGTGGACCCAAATGGGGCAG-
GCC-3
 
9
 
, was complementary to bp 851–878 of PSGAP cDNA, whereas
the second primer, 5
 
9
 
-GCCTCGCCATCCCCCAGTTTCCCCCCAG-
ATCTGTG-3
 
9
 
, was complementary to bp 936–971 of PSGAP cDNA.
PCR products were purified and subcloned into the TA vector (Invitro-
gen), and positive clones were sequenced. The Blast program from NCBI
and the Smart program from EMBL were used for sequence analysis
(Schultz et al., 1998).
 
Expression Vectors
 
To generate GST-fusion proteins, cDNAs encoding PSGAP PH/GAP
(amino acid residues 265–590), PSGAP-PH (amino acid residues 265–
453), and PSGAP-SH3 (amino acid residues 731–786) were amplified by
PCR and subcloned into pGEX-2T vector using BamHI and EcoRI sites.
Full-length FAK and PYK2 were subcloned into mammalian expression
vectors downstream of a Myc epitope (MEQKLISEEDL) under the con-
trol of the cytomegalovirus (CMV) promoter (pCMV-c-Myc) (Xiong and
Parsons, 1997). cDNAs encoding PSGAP or its mutants were subcloned
into mammalian expression vectors downstream of a Flag epitope
(MDYKDDDDKGP) under the control of the CMV promoter. Point mu-
tations in PYK2 or PSGAP were generated by site-directed mutagenesis
using Quick Change kit (Stratagene). The authenticity of all mutants was
verified by DNA sequencing.
 
GST Pull-Down Assays
 
Transiently transfected HEK293 cells were lysed in modified RIPA buffer
(50 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 1% NP-40, 0.25% so- 
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dium-deoxycholate, and proteinase inhibitors). Cell lysates were pre-
cleared with GST immobilized on glutathione-sepharose 4B (Amersham
Pharmacia Biotech), and then incubated with GST fusion proteins (2–5
 
m
 
g) immobilized on glutathione-sepharose beads at 4
 
8
 
C for 1 h with con-
stant rocking. Beads were washed three times with modified RIPA buffer
and assayed for bound proteins by immunoblotting.
 
Cell Culture and Transfection
 
HEK293 cells and 10T1/2 fibroblasts were maintained in DMEM supple-
mented with 10% fetal calf serum, 100 
 
m
 
g/ml penicillin G, and 100 
 
m
 
g/ml
streptomycin (GIBCO BRL). For HEK293 cell transfection experiments,
cells were plated for 12 h at a density of 10
 
6
 
 cells/10-cm culture dish, and
were transfected using the calcium phosphate precipitation method. 24–
36 h after transfection, cells were lysed in the modified RIPA buffer. Ly-
sates were subjected to immunoprecipitation or immunoblotting. For
 
10T1/2 cell transfection, cells were transfected with 30–40 
 
m
 
l of lipo-
fectamine (GIBCO BRL) or superinfect (Invitrogen) with various con-
structs (3–4 
 
m
 
g DNA) in DMEM serum-free medium. After incubation
for 5 h, serum-containing medium was added. 24 h later, cells were
trypsinized, replated on fibronectin-coated cover slips, and fixed with 4%
paraformaldehyde for immunostaining.
 
Immunoprecipitation and Immunoblotting
 
Immunoprecipitation of individual proteins was carried out as previously
described (Xiong et al., 1998). In brief, cell lysates (1 mg protein) were
incubated with antibodies (1–10 
 
m
 
g) at 4
 
8
 
C for 1 h in a final volume of 1
ml modified RIPA buffer with constant rocking. After the addition of
protein A-agarose beads, reactions were incubated at 4
 
8
 
C for 1 h. Im-
mune complexes were resolved by SDS-PAGE and subjected to immu-
noblotting.
Figure 1. Cloning of PSGAP, a
novel rhoGAP-containing pro-
tein that interacts with PYK2.
(A) Deduced amino acid se-
quences of mouse PSGAP-m
and PSGAP-s. Filled arrows
indicate the two methionines
as the translational starting
codons for the splice variants,
PSGAP-m (786 amino acids)
and PSGAP-s (683 amino ac-
ids), respectively. PSGAP-m
contains a different amino ter-
minus (z103 amino acids) that
is underlined with dots. The
PH domain (amino acids 267–
370 in PSGAP-m) is under-
lined, rhoGAP domain (amino
acids 398–571 in PSGAP-m) is
underlined with dashed lines,
the proline rich motif is indi-
cated by stars, and the SH3 do-
main (amino acids 733–786 in
PSGAP-m) is boxed. The orig-
inal clone isolated by yeast
two-hybrid screen contains
amino acids 265–786. (B) Com-
parison of the partial human
and mouse PSGAP protein se-
quences. Partial human PS-
GAP (hu-PSGAP) (279 amino
acids) were obtained by
searching human EST data-
bases, which corresponded to
the residues of 508–786 of mouse
PSGAP-m (mo-PSGAP-m) with
84% identity. Stars indicate
identical residues. (C) Se-
quence alignment of PH do-
mains of mouse PSGAP-m, hu-
man Graf, and oligophrenin-1.
(D) Sequence alignment of the
RhoGAP domains of mo-
PSGAP-m, hu-Graf, Oligo-
phrenin-1, HAT-2. (E) Se-
quence alignment of the SH3
domains of mo-PSGAP-m, hu-
Graf, and myosin 1C. Align-
ments were determined using
the program pileup from the
Genetics Computer Group. (C, D, and E) Identical residues are boxed. (F) Comparison of domain structures of mo-PSGAP-m,
mo-PSGAP-s, hu-Graf, and oligophrenin-1. The PH, rhoGAP, and SH3 domains are indicated. The amino acid identities (%)
within a specific domain are shown.  
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Northern Blotting
 
To study mRNA distribution in different tissues, an RNA filter compris-
ing poly(A)-selected RNAs of multiple mouse tissues (CLONTECH Lab-
oratories, Inc.) was hybridized with specific 
 
32
 
P-labeled cDNAs as de-
scribed previously (Xiong et al., 1994). In brief, mouse PSGAP probe (bp
796–1358) or human Graf probe (bp 1–717 in KIAA 0621) was radiola-
beled with [
 
a
 
-
 
32
 
P]CTP by nick translation using random primers. Probes
(
 
z
 
4 
 
3
 
 10
 
8 
 
cpm/
 
m
 
g) were hybridized with the RNA filter overnight at 42
 
8
 
C
and washed twice (30 min) in 0.2
 
3 
 
SSC–0.1% SDS at room temperature,
and at 45
 
8
 
C. Autoradiograms were obtained by exposure of blots to XAR
film (Eastman Kodak Co.) for 2–24 h.
 
Immunocytochemistry
 
Cells were fixed with 4% paraformaldehyde for 20 min, blocked with 10%
BSA, and incubated with antibodies against PSGAP (rabbit polyclonal),
PYK2 (goat polyclonal; Santa Cruz Biotechnology, Inc.), or paxillin (mono-
clonal; Transduction Laboratories). Double-label immunostaining was
done with appropriate fluorochrome-conjugated secondary antibodies. Flu-
orescent images of cells were captured on a CCD camera (Sony) mounted
on a E600 microscope (Nikon) using Photoshop imaging software.
 
RhoGAP Assays
 
In vitro RhoGAP assay was carried out as described previously (Hilde-
brand et al., 1996). In brief, RhoA, Rac1, Cdc42 (gifts from Alan Hall,
University College, London, UK), Ran, and PSGAP GAP domain were
expressed as GST fusion proteins in 
 
Escherichia coli
 
, purified, and cleaved
from GST. RhoA, Rac1, Cdc42, and Ran (40 ng each) were incubated
with 15 
 
m
 
Ci of [
 
g
 
-
 
32
 
P] GTP (6,000 Ci/mmol; Dupont) in loading buffer (50
mM Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM EDTA, 1 mg BSA per ml, 1
mM DTT) for 15 min at room temperature in a total volume of 30 
 
m
 
l. Af-
 
ter MgCl
 
2
 
 was added to a final concentration of 10 mM, and the GTPase
mixture was placed on ice. The GTP-loaded GTPase (final concentration
of 5 nM) was incubated with or without 1, 5, 10, or 20 nM PSGAP GAP
domain for 15 min at room temperature. The reaction was stopped with 1
ml wash buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl
 
2
 
, 1 mM DTT) and
the mixture was filtered through nitrocellulose membranes. Membranes
were washed with 10 ml of wash buffer three times, air dried, and counted
to determine the amount of [
 
g
 
-
 
32
 
P]GTP remaining.
To test RhoGAP activity in vivo, GTP-bound CDC42, Rac1, or RhoA
was
 
 
 
determined by specific binding to the p21-binding
 
 
 
domain of PAK1
(GST-PBD) or rhotekin (GST-RBD) (Fujisawa et al., 1998; del Pozo et
al., 2000). In brief, cell lysates expressing Myc-tagged wild-type small GTP-
ases (CDC42, Rac1, or RhoA) with or without Flag-tagged PSGAP were
incubated with 5 
 
m
 
g of recombinant GST-PBD, or GST-RBD conjugated
with glutathione-agarose beads (Amersham Pharmacia Biotech)
 
 
 
for 60
min at 4°C, washed with lysis buffer, and eluted
 
 
 
with SDS sample buffer.
Bound CDC42, Rac, or Rho was analyzed by Western blotting
 
 
 
using anti–
Myc antibodies (Santa Cruz Biotechnology, Inc.). Whole-cell lysates were
also analyzed for
 
 
 
the presence of expressed CDC42, Rac, RhoA, and PS-
GAP for normalization.
 
Nucleotide Sequence Accession Number
 
The nucleotide sequences of the PSGAP cDNAs have been given the Gen-
Bank accessions numbers AF297029 (PSGAP-s) and AF297030 (PSGAP-m).
 
Results
 
Identification and Molecular Cloning of a Novel PYK2 
Interacting RhoGAP Protein, PSGAP
 
To identify proteins that bind to PYK2, we used the yeast
two-hybrid system. Using the PYK2 COOH terminus
(amino acids 781–1009) as bait, a positive clone was iso-
lated from a mouse brain cDNA library. Sequence analysis
revealed that this clone contained an insert of 
 
z
 
2.5 kb
with a predicted open reading frame of 526 amino acids
contiguous with the GAL4 activation domain (Gal4AD),
missing an apparent NH
 
2
 
 terminus. RACE-PCR was used
to isolate 5
 
9
 
cDNA from a mouse brain cDNA. Two splice
variants that overlapped with the original cDNA clone
were isolated. Both share a common COOH-terminal cod-
ing sequence, but vary in the positions of their starting
codons and in the sequences of their respective 5
 
9
 
-untrans-
lated regions. Whereas one isoform encoded a protein of
786 amino acids, the other splice variant appeared use me-
thionine 104 as the translational starting codon (indicated
by an arrow), resulting in an open reading frame for a pro-
tein of 683 amino acids (Fig. 1 A). By searching the human
EST databases, we were able to obtain a partial human
cDNA clone that corresponded to the residues of 508–786
of the mouse clone with 84% identity (Fig. 1 B).
Protein structural analysis using SMART program
(Schultz et al., 1998) revealed that this novel protein con-
tained multiple domains, including a PH domain, a
RhoGAP domain, and a SH3 domain in the COOH-termi-
nal region (Fig. 1, A and F). Therefore, we named this pro-
tein PSGAP. The PH domain of PSGAP located from
amino acid 267 to 370 showed homology to the PH domain
of centaurin 
 
a
 
 (a PH domain containing ArfGAP protein)
(Hammonds-Odie et al., 1996). Interestingly, Graf, a pre-
viously identified FAK and PYK2-interacting rhoGAP
protein (Hildebrand et al., 1996), and oligophrenin 1, a
protein implicated in mental retardation (Billuart et al.,
1998), also contained PH domains that were highly related
to that of PSGAP (Fig. 1 C). The centrally located
RhoGAP domain (residues 398–571) was highly homolo-
Figure 2. Expression of PSGAP and Graf mRNAs in various tis-
sues. Northern blot analyses were carried out using a multiple tis-
sue blot (CLONTECH Laboratories, Inc.). Mouse cDNA frag-
ments (796–1,358 bp for PSGAP and 1–717 bp of KIAA0621 for
Graf) were labeled with [32P-a]dCTP by the random prime
method and hybridized with the blot. A major transcript at 3.8 kb
was detected for PSGAP (top, solid arrow). In addition, two
more PSGAP transcripts, at 6 and 8 kb, respectively, were de-
tected (top, open arrows). Graf transcript was detected at z9 kb
(bottom, arrow). Molecular weight markers are indicated (left). 
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gous to rhoGAP domains of Graf, oligophrenin 1, and
HAT-2 (George and Clayton, 1992) (Fig. 1 D). The SH3
domain (residues 733–786) shared homology with SH3 do-
mains of several proteins including Graf and myosin 1C
(Fig. 1 E). The overall structure of PSGAP resembled that
of Graf, and PSGAP showed high homology to Graf with
68% identity in amino terminal regions, 59% in PH do-
mains, 69% in rhoGAP domains, and 68% in SH3 do-
mains (Fig. 1 F). PSGAP was also highly homologous to
oligophrenin 1 in the amino terminus (52% identity), PH
domain (50% identity), and rhoGAP domain (57% iden-
tity) (Fig. 1 F). These results indicate that PSGAP and
Graf comprise a novel family of rhoGAP proteins that in-
teract with PYK2 and FAK.
 
Differential Distribution between PSGAP and Graf
 
We compared mRNA expression patterns of PSGAP and
Graf by Northern blot analysis. Three RNA transcripts of
PSGAP were detected at 
 
z
 
8, 6, and 3.8 kb, suggesting that
there may be splice variants of PSGAP mRNAs as re-
vealed by cDNA cloning. Of the three transcripts, the 3.8
kb appeared most abundant and was expressed at high lev-
els in the testis, heart, lung, skeletal muscle, kidney, and
brain, with a low level of expression in the spleen (Fig. 2).
In contrast, expression of Graf was different from that of
PSGAP. First, its transcript was detected as a single band
at 9 kb. Second, Graf was highly expressed in the brain
and heart, at low levels in the lung and skeletal muscle, but
undetectable in the liver and skeletal muscle (Fig. 2).
To characterize PSGAP protein distribution, specific anti-
bodies were raised in rabbits using a recombinant PSGAP
protein (amino acids 731–786) as an antigen. Western blot
 
analysis detected three protein bands of 
 
z
 
140, 95, and 85
kD (Fig. 3 A). These bands were recognized by the antibod-
ies, but not preimmune sera (data not shown). Preabsorp-
tion of antibodies with the antigen inhibited their ability to
detect all three bands (Fig. 3 A). Furthermore, although
Graf and PSGAP share a high homology of sequences, the
PSGAP antibodies did not cross react with Graf, whose ex-
pression was evident by immunoblotting with anti–Flag anti-
bodies (Fig. 3 A). These results suggest that the three bands
represent specifically three variants of PSGAP, which may
be generated by mRNA splicing as revealed by Northern
blot analysis. The 95- and 85-kD proteins appeared to be en-
coded by the two identified splice variants, PSGAP-m (786
amino acids) and PSGAP-s (683 amino acids), respectively,
since expression of both transcripts yielded proteins of simi-
lar molecular masses (Fig. 3 A). In addition, the three PS-
GAP isoforms exhibited a unique expression pattern. The
95-kD protein (PSGAP-m) was expressed in fibroblastic cell
lines, including 10T1/2, 3Y1, and Swiss 3T3 fibroblasts,
whereas the 140- and 85-kD (PSGAP-s) proteins appeared
to be expressed ubiquitously with a relatively high level in
tumor cell lines including prostate (PC3 and LnCap) and co-
lon (DLD-1) cancer cells (Fig. 3 B).
 
Dependence of PSGAP Binding to PYK2 on the 
PSGAP’s SH3 Domain and PYK2’s Proline-rich Region
 
To understand the mechanism of the PSGAP–PYK2 inter-
action, we mapped the domain in PSGAP required for in-
teraction in yeast two-hybrid assays. As shown in Fig. 4 A,
deletion of the SH3 domain (PSGAP
 
D
 
SH3) inhibited al-
most completely PSGAP binding to PYK2. Moreover, PS-
GAP SH3 domain (PSGAP-SH3) alone was able to bind
Figure 3. Expression of PSGAP in various cells.
(A) Characterization of anti–PSGAP antibody.
A GST fusion protein containing the mouse PS-
GAP SH3 domain (amino acids 731–786) was
used to generate rabbit polyclonal antibodies as
described in Materials and Methods. Lysates (10
mg protein) of 293 cells expressing Flag-tagged
PSGAP (PSGAP-m and PSGAP-s) and Graf,
and other indicated cell lysates (20 mg protein)
were resolved on SDS-PAGE and subjected to
immunoblotting with anti–PSGAP antibodies,
antibodies preabsorbed with the GST-PSGAP
antigen, or an anti–Flag antibody. (B) Western
blot analysis of PSGAP expression. Lysates (20
mg protein) of various cells were resolved on
SDS-PAGE and subjected to immunoblotting
with anti–PSGAP antibodies (6 mg protein of
HEK293 cells expressing PSGAP was loaded).
(Solid arrows) Transfected PSGAP and endoge-
nously expressed PSGAP. Molecular weight
markers are indicated (left). 
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to PYK2. These data indicated that the SH3 domain of PS-
GAP was required and sufficient for the binding to PYK2
in yeast two-hybrid system.
We next examined the ability of PSGAP SH3 domain to
bind to PYK2 in pull-down assays. Lysates from cells trans-
fected with Myc-tagged PYK2 were incubated with differ-
ent GST fusion proteins immobilized on beads (Fig. 4 B).
Consistent with results from yeast two-hybrid assays, GST-
PSGAP-SH3 fusion protein was able to precipitate PYK2,
whereas little PYK2 was pulled down by GST alone, or
GST-PSGAP fusion proteins without SH3 domain (GST-
PSGAP-PH/GAP and GST-PSGAP-PH) (Fig. 4 B), further
indicating the requirement of and sufficiency for the PS-
GAP SH3 domain to mediate the interaction with PYK2.
The dependence of the PSGAP–PYK2 interaction on
PSGAP’s SH3 domain suggests the importance of proline-
rich sequences in PYK2. PYK2 COOH-terminal domain
contains two proline-rich regions that may function as
ligands for SH3 domains. The first proline-rich motif spans
residues 712–719 (PPPKPSR). However, this proline-rich
 
sequence of PYK2 appeared dispensable in the PSGAP–
PYK2 interaction, since mutations of this motif either by
deletion or a site-directed mutagenesis had no apparent
effect on PSGAP binding to PYK2 in yeast two-hybrid as-
says (Fig. 5). The second proline-rich motif contains the
sequence PPQKPPR (residues 855–861). This proline-rich
motif appeared to be critical for the interaction, since dele-
tion of the region (amino acids 838–869) containing this
motif abolished the interaction (Fig. 5 A). The failure of
PYK2
 
D
 
1-869 or PYK2-Nterm to interact with PSGAP was
not due to improper expression of these constructs. As
shown in Fig. 5 A, PYK2
 
D
 
1-869 and PYK2-Nterm were
expressed and were able to interact with Hic5 (a paxillin-
related protein) or m-rdgB (the mouse homologue of
 
Drosophila
 
 rdgB), respectively. To further ascertain the
role of this proline-rich sequence in PYK2-PSGAP inter-
action, we mutated prolines to alanines and characterized
the binding of PSGAP to PYK2 and its mutants. As shown
in Fig. 5 B, a point mutation in proline 859 or double mu-
tations in prolines 717 and 859 significantly reduced PS-
GAP binding to PYK2, suggesting that this second
proline-rich sequence was critical for PYK2 binding to PS-
GAP. In contrast, PYK2 binding to the PSGAP-related
protein Graf required both the first and second proline-
rich motifs (Fig. 5 B). While mutation in either proline 717
or 859 reduced the binding significantly, only the double
mutant was able to nearly abolish the interaction of Graf
to PYK2 (Fig. 5 B).
 
Interaction of PYK2 and FAK with PSGAP In Vivo
 
To determine whether PYK2 and FAK interact with PS-
GAP in vivo, we examined their association in HEK293
cells transfected with Flag-tagged PSGAP with Myc-
tagged PYK2 or FAK. Lysates of transfected cells were in-
cubated with anti–Flag antibodies immobilized on beads.
PSGAP-interacting proteins were purified by immunopre-
cipitation followed by immunoblotting with anti–Myc anti-
bodies. PYK2 and FAK were detected in immunoprecipi-
tates of PSGAP (Fig. 6 A), suggesting that PYK2 and FAK
associated with PSGAP in mammalian cells. Again, the in-
teraction of PYK2 with PSGAP required the SH3 domain
of PSGAP because a mutant with deletion of the SH3 do-
main (PSGAP
 
D
 
SH3) failed to interact with PYK2 (Fig. 6
A). This interaction was unaffected by the addition of 103
amino acid residues in the NH
 
2
 
 terminus of PSGAP-m iso-
form, since similar amounts of PSGAP-m and PSGAP-s
were observed in PYK2 immunoprecipitates (data not
shown). To further assess the ability of endogenous PYK2
to bind PSGAP, the in vivo coimmunoprecipitation be-
tween PSGAP and PYK2 was carried out in 10T1/2 fibro-
blasts and in HEK293 cells, where both PYK2 and PSGAP
were expressed endogenously. As observed with trans-
fected cells, 1–5% PYK2 was recovered in PSGAP immu-
nocomplexes, but not in preimmune complexes (Fig. 6 B),
indicating that PSGAP associates with PYK2 in vivo.
 
Stimulation of GTPase Activity of CDC42 and RhoA
by PSGAP
 
To assess the GTPase-activating activity of PSGAP, we
constructed a GST fusion protein containing the entire
GAP domain (residues 390–590) and assayed its ability to
activate GTPase activity of GTP-bound CDC42, Rac1,
Figure 4. SH3 domain of PSGAP is essential for the interaction
with PYK2. (A) Mapping of the binding region in PSGAP by
yeast two-hybrid assays. Yeast cells were cotransformed with a
vector encoding the Gal4 binding domain fused to different PS-
GAP constructs and Gal4AD fused to PYK2. Transformed yeast
cells were seeded in Leu2, Trp2, and His2 plates and assayed for
b-Gal activity. Transformed yeast cells were also grown in Leu2
and Trp2 medium for liquid b-Gal assays. (B) Analysis of PS-
GAP binding to PYK2 by in vitro GST pull-down assays.
HEK293 cells were transfected with Myc-tagged PYK2. Lysates
of transfected cells were incubated with various GST-PSGAP fu-
sion proteins (SH3, amino acids 731–786; PH-GAP, amino acids
265–590; and PH, amino acids 265–454) immobilized on beads.
Lysate input and bound proteins were resolved on SDS-PAGE
and subjected to immunoblotting with an anti–Myc antibody
(top). An equal amount of GST fusion proteins was used as re-
vealed by Coomassie staining (bottom). 
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and RhoA. Purified small G proteins (RhoA, Rac1,
CDC42, and Ran) were loaded with [
 
g
 
-
 
32
 
P]GTP and incu-
bated with different concentrations of PSGAP GAP do-
main. The GTPase-activating activity was determined by
measuring the ratio of GTPase-bound radioactivity with-
out GAP domain versus that with the GAP domain. As
shown in Fig. 7 A, the PSGAP GAP domain was able to
stimulate the intrinsic GTPase activity of RhoA and
CDC42 in a concentration-dependent manner. However,
the effects of the PSGAP GAP domain on the GTPase ac-
tivity of Rac1 and Ran were undetectable. These results
indicate that CDC42 and RhoA may be preferred sub-
strates for PSGAP in the cell-free system.
The GTP-bound Rho family GTPases bind to down-
stream proteins specifically and with high affinity. For ex-
ample, activated CDC42 or Rac binds to PAK1, while acti-
vated RhoA binds to rhotekin specifically (Reid et al.,
1996; Van Aelst and D’Souza-Schorey, 1997; Hall, 1998).
To assess the GTPase-activating activity of PSGAP in
vivo, GST-PBD or GST-RBD was used to isolate acti-
vated small G proteins from cell lysates coexpressing wild-
type CDC42, Rac, or RhoA and PSGAP (Reid et al., 1996;
del Pozo et al., 2000). As shown in Fig. 7 B, while a similar
amount of CDC42 and RhoA was expressed in transfected
cells, the amount of precipitated active CDC42 and RhoA
was significantly lower in cells expressing PSGAP, indicat-
ing that PSGAP-stimulated GTPase activities of CDC42
and RhoA in vivo (Fig. 7 B). However, the GTPase-acti-
vating activity of PSGAP towards Rac1 was undetectable
in this assay (Fig. 7 B). These results suggest that CDC42
and RhoA may be substrates for PSGAP in vivo.
 
Differential Regulation of PSGAP and CDC42 by 
PYK2 and FAK
While both PYK2 and FAK interacted with PSGAP, ef-
fects of PYK2 and/or FAK on PSGAP were unknown. To
address this question, we first examined whether PSGAP
could be tyrosine phosphorylated by PYK2 or FAK. PS-
GAP was cotransfected in HEK293 cells with wild-type,
mutant PYK2, or FAK. Tyrosine phosphorylation was re-
vealed by immunoprecipitation and immunoblotting using
Figure 5. Proline 859 in PYK2 is
required for PSGAP binding.
(A) Analyses of PYK2 domains
essential for binding to PSGAP
by yeast two-hybrid filter assays.
Yeast cells were cotransformed
with a vector encoding the Gal4
binding domain (Gal4-BD)
fused to different constructs of
PYK2, or FAK and Gal4AD/
PSGAP. Gal4AD/Hic5 and
Gal4AD/mrdgB were used as
controls. Transformed yeast
cells were seeded in Leu2, Trp2,
and His2 plates and scored for
growth and b-Gal activity (blue
color). (2) No blue color in the
yeast after 24 h in reaction, (1)
blue reaction after 4 h, (111)
blue reaction after 30 min. (B)
Reduction of the ability of
P859A mutant to bind PSGAP
in yeast two-hybrid liquid as-
says. Yeast cells were cotrans-
formed with a vector encoding
the Gal4 DB fused to SH3 do-
main of PSGAP or Graf and
wild-type or mutant PYK2 in
Gal4AD. Transformed yeast
cells were grown in His2, Leu2,
and Trp2 medium for liquid
b-Gal assays. *P  , 0.05 and
**P , 0.01 in comparison with
PYK2-WT, Student’s t test.The Journal of Cell Biology, Volume 152, 2001 978
antibodies against phosphotyrosine. As shown in Fig. 8 A,
PSGAP was tyrosine phosphorylated in cells coexpressing
PYK2. Tyrosine phosphorylation of PSGAP was dimin-
ished in cells coexpressing PYK2-KD (a catalytically inac-
tive PYK2) or PYK2-Y402F (an autophosphorylation mu-
tant), suggesting the involvement of PYK2 kinase activity
and autophosphorylation in this event. In contrast, PS-
GAP was not tyrosine phosphorylated by FAK (Fig. 8 A).
These results suggest that the regulation of PSGAP by
PYK2 may be different from that by FAK. To further ad-
dress the differential effects of PYK2 and FAK on PS-
GAP, we examined whether PYK2 and FAK affected
PSGAP’s regulation of GTPase activity of CDC42. GST-
PBD binding to CDC42 in cell lysates coexpressing PS-
GAP and PYK2 or FAK was carried out. While PSGAP
exhibited significant reduction of the precipitated GTP-
bound CDC42 (Fig. 8 B), coexpressing PYK2 increased
the GTP-bound CDC42, suggesting that PSGAP’s nega-
tive effect on CDC42-GTP loading was abolished when
PYK2 was coexpressed (Fig. 8 B). PYK2-mediated inhibi-
tion of PSGAP depended on PYK2 binding to PSGAP,
since mutations in PYK2 (PYK2-P859A) or PSGAP
(PSGAPDSH3) that block the interaction of PYK2 with
PSGAP failed to exhibit such inhibitory effect (Fig. 8 B).
Interestingly, although FAK was able to interact with PS-
GAP, it seemed unable to regulate PSGAP (Fig. 8 B).
These results further indicated that PYK2 and FAK regu-
lated PSGAP differently.
PYK2 inhibition of PSGAP’s effect on CDC42 suggested
that PYK2 might activate CDC42. To test this hypothesis,
we examined whether PYK2 increases the GTP loading of
CDC42 when PYK2 was coexpressed with small GTP-bind-
ing proteins. As we expected, expressing PYK2 indeed in-
creased the GTP-bound CDC42, but not Rac (Fig. 9 A). In-
terestingly, PYK2-induced activation of CDC42 appeared
to require PYK2 catalytic activity and binding to PSGAP,
since the catalytic inactive mutant (PYK2-KD) and mutant
that did not bind PSGAP (PYK2-P859A) failed to increase
GTP-bound CDC42 (Fig. 9 B). Remarkably, GTP-bound
CDC42 was increased only in cells expressing PYK2, but
not FAK (Fig. 9 B), suggesting again the differential regula-
tion of CDC42 between PYK2 and FAK.
Subcellular Localization of PSGAP in Fibroblasts
Subcellular localization of PSGAP was characterized in
10T1/2 fibroblasts that expressed PSGAP, PYK2, and
FAK endogenously. 10T1/2 cells were plated on fibronec-
tin-coated cover slips, fixed, and immunostained using an-
tibodies against PSGAP (polyclonal) and paxillin (mono-
clonal). As shown in Fig. 10, PSGAP was distributed in
perinuclear regions as well as in peripheral regions as
punctuate aggregates where paxillin was also localized.
The staining was specific, since it could be blocked by the
PSGAP antigen (Fig. 10 A). Interestingly, the punctuate
cell periphery staining of PSGAP appeared to be a transi-
tory event. It only appeared in cells grown on fibronectin-
coated cover slips within 90 min (data not shown). Re-
markably, PYK2 was also localized at the cell periphery in
addition to the perinuclear regions as well as focal contacts
(Fig. 10 B). To confirm the subcellular localization of PS-
GAP, we examined the distribution of the transfected PS-
GAP in 10T1/2 cells. As described in the following section,
when PSGAP was overexpressed, it caused abnormal
morphology. Thus, the subcellular localization of trans-
fected PSGAP was studied in cells with a low level of
transfected PSGAP. Consistent with endogenous PSGAP,
transfected PSGAP was distributed in perinuclear and
cell-periphery regions (Fig. 10 C).
To determine which domains of PSGAP were required
for its cell periphery localization, we generated mutants
with deletions of either NH2 terminus (PSGAPDN, aa1-
265 deleted) or the NH2 terminus and PH domain (PS-
GAPDPH, amino acids 1–390 deleted). While PSGAPDN
exhibited a similar localization pattern as the wild type,
there was little, if any, staining of PSGAPDPH at the cell
periphery (Fig. 10 C). These results indicated that the PH
domain was critical for PSGAP cell periphery localization.
Cytoskeletal Reorganization in Fibroblasts
Expressing PSGAP
To study potential roles of PSGAP in regulating cytoskel-
etal organization, we examined the cytoskeletal organiza-
tion and cellular morphology in 10T1/2 fibroblasts ex-
pressing PSGAP or its mutants. Expression of wild-type
Figure 6. Interaction of PSGAP with PYK2 and FAK in vivo.
(A) Coimmunoprecipitation of PSGAP with PYK2 or FAK in
mammalian-expressing cells. HEK293 cells cotransfected Myc-
tagged PYK2 or FAK with Flag-tagged PSGAP or PSGAPDSH3
were lysed. Immunoprecipitations (IP) with Flag antibody was
revealed by immunoblotting (IB) with anti–Myc (top) or anti–
Flag (middle) antibodies. Expression of PYK2 and FAK was
demonstrated at bottom. (B) Coimmunoprecipitation of PSGAP
with PYK2 in vivo. Cell lysates from HEK293 or 10T1/2 cells
were immunoprecipitated with PSGAP antibodies and immuno-
blotted with PYK2 antibodies. (Solid arrow) PYK2; (open ar-
rows) PSGAP.Ren et al. PYK2 and PSGAP 979
PSGAP disrupted focal adhesions and cell morphology in
approximately half of transfected cells (Fig. 11). The num-
ber (73–75%) of cells with disorganized cytoskeleton or
abnormal morphology increased in cells expressing PS-
GAPDN or PSGAPDPH, indicating that the NH2 terminus
and PH domains were not required for these events. To
examine whether rhoGAP activity was required for PS-
GAP-mediated disorganization of cytoskeleton, we gener-
ated a rhoGAP-inactive mutant (PSGAPDN-GD) con-
taining an arginine 424-to-glutamine mutation in the GAP
domain (Fig. 11 B). Arginine 424 in PSGAP is conserved
with arginine 85 in p50rhoGAP, a critical residue for the
direct contacts with CDC42 (Barrett et al., 1997; Rittinger
et al., 1997). Mutation of this residue rendered many
rhoGAP proteins enzymatically inactive (Barrett et al.,
1997; Rittinger et al., 1997; Taylor et al., 1999). Indeed, PS-
GAPDN-GD was unable to stimulate CDC42 or RhoA
GTPase activity in vitro (data not shown). Remarkably, a
majority of cells expressing PSGAPDN-GD exhibited nor-
mal focal adhesions and cellular morphology (Fig. 11), in-
dicating that the rhoGAP activity was required for PS-
GAP-mediated cytoskeletal reorganization.
Discussion
This paper described identification and characterization
of PSGAP, a novel PYK2-interacting protein that may
play a pivotal role in PYK2 regulation of cytoskeleton.
PSGAP interacts with PYK2 via the COOH-terminal
SH3 domain and PYK2’s proline-rich region. In addition
to the SH3 domain, PSGAP has a PH domain and a
RhoGAP domain. These domains appear to be of func-
tional importance. The PH domain is essential for subcel-
lular localization, whereas the rhoGAP domain stimu-
lates CDC42 and RhoA GTPase activity and is required
for PSGAP-mediated cytoskeletal reorganization. Fur-
thermore, we provide evidence that the interaction of
PYK2 with PSGAP regulates the activation of CDC42
GTPase. These results suggest that PSGAP is an impor-
tant mediator for PYK2 to regulate Rho-family GTPases,
Figure 7. GTPase-activating ac-
tivity of PSGAP. (A) Character-
ization of GTPase-activating ac-
tivity of PSGAP in vitro.
Recombinant proteins of RhoA,
Rac1, CDC42, and Ran GTP-
ases were loaded with [g-32P]
GTP and incubated without or
with increasing concentrations
of PSGAP GAP domain. Hy-
drolyzed and GTPase-bound ra-
dioactive GTP was determined
by nitrocellulose filtration assay
as described in Materials and
Methods. Fold activation repre-
sents the ratio of radioactivity
remaining after incubation in
the absence of GAP domain
versus the amount of radioactiv-
ity remaining after incubation in
the presence of GAP domain.
(B) Analysis of the effects of PS-
GAP on GST-PBD or GST-
RBD binding to transfected
small G proteins. HEK293 cells
were transfected with wild-type,
active, or inactive mutants of
Rac1, CDC42, or RhoA (all
Myc-tagged) with or without
Flag-tagged PSGAP. Cell ly-
sates were incubated with GST-
PBD or GST-RBD immobi-
lized on beads. Bound small G
proteins were resolved on SDS-
PAGE and detected by immu-
noblotting (top). Equal amounts
of small G proteins were ex-
pressed as shown in the mid-
dle. (Bottom) Expression of
PSGAP.The Journal of Cell Biology, Volume 152, 2001 980
providing insight into mechanisms by which PYK2 regu-
lates cytoskeletal organization.
SH3 domains are important in mediating protein–pro-
tein interactions or directing cell compartmentalization
(Koch et al., 1991; Bar-Sagi et al., 1993). PSGAP SH3 do-
main alone, but not PSGAP with the deletion of SH3 do-
main, interacts with PYK2, demonstrating that the SH3
domain mediates the protein–protein interaction. The
ligand for PSGAP SH3 domain appears to be the second
proline-rich sequence (residues 874–880), PPQKPPR, at
the COOH terminus of PYK2. This proline-rich motif be-
longs to class II ligands of SH3 domains (Feng et al.,
1994) and is conserved in FAK. Indeed, FAK can interact
with PSGAP in vitro and in vivo. On the other hand, this
motif also binds to other SH3 domain containing GAP
proteins including Graf and Paps, a PH and SH3 domain
containing ArfGAP protein (Andreev et al., 1999). We
speculate that these binding proteins may compete with
PSGAP to interact with PYK2 or FAK, and that PYK2
and FAK may regulate different GAP proteins in differ-
ent subcellular compartments.
PSGAP is localized at the cell periphery, which ap-
pears to correspond to the cell membrane. Interestingly,
such localization occurs in a PH domain–dependent man-
ner. PH domains are small protein modules of z120
amino acids found in many proteins involved in cell sig-
naling and cytoskeletal rearrangement (Blomberg et al.,
1999). PH domains function as membrane targeting sig-
nals and bind specifically to phosphoinositides (Blom-
berg et al., 1999). The exact ligand of the PH domain of
PSGAP is not yet known. It is possible that phospho-
inositides regulated by integrin stimulation may be im-
portant for PSGAP localization and rhoGAP activity.
The transient cell periphery localization of PSGAP dur-
ing integrin-mediated cell spreading (data not shown)
suggests that function of the PSGAP PH domain may be
regulated by integrin stimulation.
The presence of a RhoGAP domain in PSGAP suggests
to us that PSGAP contains an intrinsic GTPase activating
activity for Rho family proteins. Indeed, the recombinant
RhoGAP domain exhibited GTPase activating activity to-
Figure 8. Regulation of PSGAP by PYK2, but not FAK. (A) Ty-
rosine phosphorylation of PSGAP by PYK2, but not FAK.
HEK293 cells were transfected with indicated constructs. Cell ly-
sates were immunoprecipitated with Flag antibodies (for PS-
GAP) and immunoblotted with antibodies against phosphoty-
rosine (Ptyr) and Flag. Open arrows indicate PSGAP. (B)
Inhibition of PSGAP’s effect on CDC42 by PYK2, but not FAK.
HEK293 cells were transfected with indicated constructs. Cell ly-
sates were incubated with GST-PBD immobilized on beads.
Bound active CDC42 was resolved on SDS-PAGE and detected
by immunoblotting. Equal amounts of CDC42 were expressed as
indicated. The expression of PYK2, FAK, and PSGAP are also
shown. (Solid arrows) CDC42; (open arrows) PYK2 or PSGAP.
Figure 9. Activation of CDC42 by PYK2, but not FAK. (A)
PYK2 activation of CDC42, but not Rac. (B) PYK2, but not
FAK, activation of CDC42 requires PYK2 catalytic activity and
its binding region to PSGAP. (A and B) HEK293 cells were
transfected with indicated constructs. Cell lysates were incubated
with GST-PBD immobilized on beads. Bound active CDC42 or
Rac was resolved on SDS-PAGE and detected by immunoblot-
ting. Equal amounts of small G proteins were expressed as indi-
cated. The expression of PYK2 and FAK are also shown. (Solid
arrows) Small G proteins; (open arrows) PYK2 or FAK.Ren et al. PYK2 and PSGAP 981
wards several small G proteins, including RhoA and
CDC42 in vitro and in vivo. It is worth noting, however,
that the substrate profile of PSGAP’s GTPase-activating
activity is different between in vitro and in vivo assays.
While it activates RhoA more than CDC42 in vitro, the
GTPase-activating activity for RhoA is weakly detected
when PSGAP is expressed in HEK293 cells. The discrep-
ancy between in vitro and in vivo GTPase-activating activ-
ities of PSGAP may result from the difference of the
assays, or different affinities of the GST-PBD and GST-
RBD to the active small G proteins. This discrepancy has
been reported previously for other GAP proteins. For ex-
ample, the substrate spectrum of p50rhoGAP in vitro en-
compasses CDC42, Rac, and Rho, whereas it appears to
be restricted to Rho in vivo (Ridley et al., 1993). The ap-
parent difference of PSGAP’s GTPase-activating activities
between in vitro and in vivo assays suggest that PSGAP
rhoGAP activity may be regulated by phospholipids and/
or subcellular localization.
Although both PYK2 and FAK bind to PSGAP, only
PYK2, but not FAK, negatively regulates the GTPase-
activating activity of PSGAP. This finding is interesting
since it provides an explanation of different functions of
PYK2 and FAK, and implicates a possibility of activation
of CDC42 by PYK2-inactivating PSGAP. Indeed, CDC42
was activated by PYK2 in HEK293 cells. Whether PYK2
activates CDC42 in vivo and how PYK2 regulates PSGAP
activity is unclear. PSGAP became tyrosine phosphory-
lated in cells overexpressing PYK2, but not FAK, implying
that PYK2-directed PSGAP phosphorylation may be a
mechanism for the regulation of PSGAP activity by PYK2.
The requirement of the PYK2 catalytic activity for the in-
hibition of PSGAP supports this speculation. It will be in-
teresting to further investigate how phosphorylation of
PSGAP regulates its GAP activity.
Although PSGAP is highly related to Graf in structure,
they are encoded by different genes. Partial cDNA encod-
ing Graf is initially cloned from chicken as a FAK-binding
protein (Hildebrand et al., 1996). Graf orthologs have been
identified in humans, including oligophrenin 1-like or
KIAA0621, which exhibit an overall sequence identity of
.90%, suggesting that Graf is evolutionarily conserved. In-
terestingly, PSGAP is also evolutionarily conserved. In ad-
dition to human orthologs of PSGAP, analysis of EST data-
base reveals clones in rat or Xenopus laevis that are highly
homologous to PSGAP, with sequence identity of 85–95%.
However, human and mouse PSGAP show z50% identities
with chicken and human Graf, suggesting that both Graf
Figure 10. Expression of PS-
GAP at the cell periphery in
10T1/2 fibroblasts. 10T1/2 cells
were fixed with 4% paraformal-
dehyde for 20 min, blocked with
10% BSA, and immunostained
with indicated antibodies. (A)
Immunostaining using antibod-
ies against PSGAP or antibodies
preabsorbed with the GST-PS-
GAP antigen. (B) Coimmu-
nostaining with anti–PSGAP or
anti–PYK2 and antipaxillin anti-
bodies. PSGAP and PYK2 were
visualized by FITC-conjugated
secondary antibodies, whereas
paxillin appeared in red with
rhodamine-conjugated second-
ary antibodies. (C) Immu-
nostaining of PSGAP wild-type
(PSGAP-WT), NH2-terminal–
deleted PSGAP (PSGAPDN),
and PH-domain–deleted PS-
GAP (PSGAPDPH) in trans-
fected 10T1/2 fibroblasts. Cells
were transfected with the indi-
cated constructs and stained
with anti–PSGAP antibodies.
Bar, 50 mm.The Journal of Cell Biology, Volume 152, 2001 982
and PSGAP are derived from two different biologically
conserved genes. Moreover, PSGAP exhibits a tissue ex-
pression pattern different from Graf. Graf is expressed in a
relatively restricted pattern, with mRNA detected in tissues
including heart and brain. In contrast, PSGAP is expressed
in a wide variety of tissues and cell lines, including testis,
heart, skeletal muscles, kidney, lung, and brain. Remark-
ably, PSGAP, but not Graf, is expressed in fibroblasts.
Thus, in fibroblasts, PSGAP, but not Graf, may be an im-
portant mediator for PYK2 or FAK to regulate cytoskeletal
organization. In terms of substrate specificity, PSGAP and
Graf are also different. While Rho is the preferred in vivo
substrate for Graf (Taylor et al., 1999), PSGAP has high
GTPase-activating activity towards CDC42 in vivo.
In summary, we have identified a novel PH and SH3 do-
main-containing rhoGAP protein, PSGAP, which inter-
acts with both PYK2 and FAK in a SH3 domain-depen-
dent manner. PSGAP, a CDC42/Rho GTPase-activating
protein, may be an important mediator for PYK2 to regu-
late cytoskeletal organization via Rho family GTPases.
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